Uses of RU 486: a clinical update.
D001695:Biology; D002264:Carboxylic Acids; D002584:Cervix Uteri; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D004467:Economics; D004703:Endocrine System; D004717:Endometrium; D005193:Family Planning Services; D013502:General Surgery; D005835:Genitalia; D005836:Genitalia, Female; D013509:Gynecologic Surgical Procedures; D007747:Labor Stage, First; D009930:Organic Chemicals; D010827:Physiology; D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D012106:Research; D013672:Technology; D013812:Therapeutics; D014566:Urogenital System; D014599:Uterus
D002264:Carboxylic Acids; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003281:Contraceptives, Postcoital; D009930:Organic Chemicals; D011448:Prostaglandin Antagonists; D011453:Prostaglandins
Biology; Carboxylic Acids; Cervical Dilatation; Cervical Effects; Cervix; Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Postcoital; Economic Factors; Endocrine System; Endometrial Effects; Endometrium; Family Planning; Fertility Control, Postcoital; Genital Effects, Female; Genitalia; Genitalia, Female; Gynecologic Surgery; Organic Chemicals; Physiology; Prostaglandin Antagonists; Prostaglandins; Research And Development; Research Methodology; Surgery; Technology; Treatment; Urogenital Effects; Urogenital Surgery; Urogenital System; Uterine Effects; Uterus